GLP-1 medications , or glucagon-like peptide-1 receptor agonists , represent a truly development in how we approach type 2 diabetes . These injectable drugs work by mimicking the body’s inherent GLP-1 https://bookmark-search.com/story21608189/glp-1-a-major-advance-in-diabetes-care